Steven F. Bellon - 25 May 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Scientific Officer
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol
FHTX
Transactions as of
25 May 2022
Net transactions value
+$14,320
Form type
4
Filing time
27 May 2022, 16:10:14 UTC
Previous filing
28 Jan 2022
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Options Exercise $493 +675 +0.58% $0.7300* 116,382 25 May 2022 Direct
transaction FHTX Common Stock Options Exercise $13,827 +3,717 +3.2% $3.72 120,099 25 May 2022 Direct
holding FHTX Common Stock 50,000 25 May 2022 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Options (Right to buy) Options Exercise $0 -675 -100% $0.000000* 0 25 May 2022 Common Stock 675 $0.7300 Direct F2
transaction FHTX Stock Options (Right to buy) Options Exercise $0 -3,717 -40% $0.000000 5,574 25 May 2022 Common Stock 3,717 $3.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
F2 The option vested at a rate of 6.25% of the underlying shares beginning on April 1, 2018 and thereafter on the first day of each calendar quarter until the option was fully vested.
F3 The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.